CLINICAL_TRIALS
trial_result
· 2022-03-22
Clinical Trial Update: STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity [Phase 3]
Summary
Phase 3 trial investigating semaglutide for overweight or obesity has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2022-03-22